Skanderbeg Capital goes quiet after stock tanks.It is just another Rinse and Repeat. They have a boiler room pushing various deals HAVN being one of them and when the deal they get you into tanks from $ .90 cents to $ .22-.23 they stop calling. They get so hyped on the deal, get their options, warrants, cheap shares and sell them off and move on. I like the biotech sector and the medical advancements in the psychoactive mushroom space should be a winner. So why were we $ 1.20 last December and heading into the teens by this December with Tax Loss Selling on the horizon.